Cargando…
Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling
Carboxypeptidase A4 (CPA4) is a member of the metallocarboxypeptidase family. Current studies have identified the roles of CPA4 in cancer biology and insulin sensitivity. However, the roles of CPA4 in other diseases are not known. In the present study, we investigated the roles of CPA4 in cardiac hy...
Autores principales: | Gao, Weinian, Guo, Na, Zhao, Shuguang, Chen, Ziying, Zhang, Wenli, Yan, Fang, Liao, Hongjuan, Chi, Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214395/ https://www.ncbi.nlm.nih.gov/pubmed/32347291 http://dx.doi.org/10.1042/BSR20200669 |
Ejemplares similares
-
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022) -
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice
por: Alharbi, Hajed O., et al.
Publicado: (2022) -
Sappanone A alleviates hypoxia/reoxygenation-induced cardiomyocytes injury through inhibition of mitochondrial apoptosis and activation of PI3K–Akt–Gsk-3β pathway
por: Shi, Xiaojing, et al.
Publicado: (2020) -
Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
por: Zhang, Xiong, et al.
Publicado: (2020) -
The Programming of Cardiac Hypertrophy in the Offspring by Maternal Obesity Is Associated with Hyperinsulinemia, AKT, ERK, and mTOR Activation
por: Fernandez-Twinn, Denise S., et al.
Publicado: (2012)